MVP Act

This bill creates official rules that let drug companies set different prices for medicines in the Medicaid Drug Rebate Program based on how well those medicines actually work for patients, which is called "value-based purchasing." It also requires a government study on how these pricing arrangements affect federal health care programs. The bill changes how certain drug prices are calculated under Medicare when these special arrangements are used and requires guidance for state Medicaid programs on how to cover drugs in hospital settings using these outcome-based pricing deals.

Your Vote